Want to see XERS full AI Analyst Report?
Xeris Pharmaceuticals (XERS) Ownership Overview
4.92% Insiders
10.49% Mutual Funds
10.46% Other Institutional Investors
13.89% ETFs
60.23% Public Companies and
Individual Investors
The ownership structure of Xeris Pharmaceuticals (XERS) stock is a mix of institutional, retail, and individual investors. Approximately 34.84% of the company’s stock is owned by Institutional Investors, 4.92% is owned by Insiders, and 60.23% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Dec 19, 2025 | xxxxxxxxxxxxx | $976234 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $128827 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $639540 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $3652332 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $2084211 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,856,915 | Institution | 4.86% | 65,984,017 | |
| 7,999,694 | Institution | 4.39% | 59,597,720 | |
| 6,806,378 | Institution | 3.73% | 50,707,516 | |
| 2,898,933 | Insider | 1.59% | 21,597,051 | |
| 2,429,002 | Institution | 1.33% | 18,096,065 | |
| 1,809,381 | Institution | 0.99% | 13,479,888 | |
| 1,717,061 | Institution | 0.94% | 12,792,104 | |
| 1,664,208 | Insider | 0.91% | 12,398,350 | |
| 1,659,732 | Institution | 0.91% | 12,365,003 | |
| 1,398,075 | Institution | 0.77% | 10,415,659 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,806,378 | Institution | 3.73% | 50,707,516 | |
| 2,429,002 | Institution | 1.33% | 18,096,065 | |
| 1,717,061 | Institution | 0.94% | 12,792,104 | |
| 1,659,732 | Institution | 0.91% | 12,365,003 | |
| 913,357 | Institution | 0.50% | 6,804,510 | |
| 615,038 | Institution | 0.34% | 4,582,033 | |
| 525,351 | Institution | 0.29% | 3,913,865 | |
| 490,039 | Institution | 0.27% | 3,650,791 | |
| 484,655 | Institution | 0.27% | 3,610,680 | |
| 402,327 | Institution | 0.22% | 2,997,336 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,193,656 | Institution | 2.85% | 41,964,740 | |
| 4,374,051 | Institution | 2.40% | 32,586,680 | |
| 1,989,455 | Institution | 1.09% | 16,074,796 | |
| 1,599,956 | Institution | 0.88% | 11,919,672 | |
| 1,102,839 | Institution | 0.60% | 8,458,775 | |
| 974,240 | Institution | 0.53% | 7,258,088 | |
| 962,037 | Institution | 0.53% | 7,773,259 | |
| 830,590 | Institution | 0.46% | 6,370,625 | |
| 825,069 | Institution | 0.45% | 6,146,764 | |
| 654,710 | Institution | 0.36% | 4,877,590 |
FAQ
Who Owns Xeris Pharmaceuticals (XERS)?
According to the latest TipRanks data, approximately 10.46% of the company's stock is held by institutional investors, 4.92% is held by insiders, and 60.23% is held by retail investors.
What percentage of Xeris Pharmaceuticals (XERS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 10.46% of Xeris Pharmaceuticals (XERS) stock is held by institutional investors.
What percentage of Xeris Pharmaceuticals (XERS) stock is held by retail investors?
According to the latest TipRanks data, approximately 60.23% of Xeris Pharmaceuticals (XERS) stock is held by retail investors.
Who owns the most shares of Xeris Pharmaceuticals (XERS)?
Vanguard owns the most shares of Xeris Pharmaceuticals (XERS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.